Israeli app for adjusting insulin dosage receives FDA approval

Ynetnews Business

Israeli app for adjusting insulin dosage receives FDA approval

DreaMed Diabetes’ MODI app analyzes glucose and insulin data to deliver personalized dosing recommendations to adults with type 2 diabetes, without requiring a doctor to approve each adjustment

Read full story at source

Economy
Israel halts review of Zim sale to Hapag-Lloyd, FIMI
3h
Economy
Data centers construction will resume under strict conditions
5h
Economy
An employee or AI? A $12M Israeli startup wants to tell the difference
8h
Economy
UK expands Israel arms embargo - report
10h

Israeli app for adjusting insulin dosage receives FDA approval

More in this section

Israel halts review of Zim sale to Hapag-Lloyd, FIMI

Data centers construction will resume under strict conditions

An employee or AI? A $12M Israeli startup wants to tell the difference

UK expands Israel arms embargo - report